And the money, she is all gone, señor.

BioNTech to close 3 sites in Germany after failed buyer search – BioNTech is set to shutter multiple sites in Germany, impacting about 1,800 jobs, after efforts to find buyers fell through.

BioNTech announced plans to exit three German sites in May, as the mRNA pioneer adjusts production capacity in response to a sharp drop in global COVID-19 vaccine demand while pivoting to its developing oncology pipeline. At the time, the German company said it was exploring potential divestment options, including a partial or total sale, for the manufacturing sites.

“Despite the intensive efforts of all parties involved and a broad-based sales process, it was unfortunately not possible to realize a sale,” a BioNTech spokesperson told Fierce in a statement.